Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

XNCR

Xencor (XNCR)

Xencor Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:XNCR
DatumZeitQuelleÜberschriftSymbolFirma
26/11/202422h01Business WireXencor to Participate at Upcoming Investor ConferencesNASDAQ:XNCRXencor Inc
21/11/202422h21Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:XNCRXencor Inc
15/11/202400h38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XNCRXencor Inc
15/11/202400h16Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:XNCRXencor Inc
13/11/202423h46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XNCRXencor Inc
13/11/202422h21Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:XNCRXencor Inc
12/11/202414h33Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:XNCRXencor Inc
08/11/202420h17Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:XNCRXencor Inc
06/11/202422h09Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:XNCRXencor Inc
06/11/202422h03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XNCRXencor Inc
06/11/202422h01Business WireXencor Reports Third Quarter 2024 Financial ResultsNASDAQ:XNCRXencor Inc
04/11/202413h00Business WireXencor Doses First Subject in Phase 1/2 Study of XmAb®942 in Development for Patients with Inflammatory Bowel DiseaseNASDAQ:XNCRXencor Inc
21/10/202422h18Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:XNCRXencor Inc
18/10/202421h31Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:XNCRXencor Inc
10/10/202414h09Business WireXencor Presents Preclinical Data on XmAb942, a High-Potency Extended Half-Life Anti-TL1A Antibody, to be Developed for Patients with Inflammatory Bowel DiseasesNASDAQ:XNCRXencor Inc
04/10/202414h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XNCRXencor Inc
04/10/202414h01Business WireXencor Announces Upcoming Change to Board of DirectorsNASDAQ:XNCRXencor Inc
02/10/202422h50Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:XNCRXencor Inc
01/10/202422h13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XNCRXencor Inc
01/10/202422h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XNCRXencor Inc
01/10/202422h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XNCRXencor Inc
27/09/202416h35Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:XNCRXencor Inc
27/09/202416h12Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:XNCRXencor Inc
27/09/202415h41Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:XNCRXencor Inc
12/09/202422h02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XNCRXencor Inc
12/09/202422h01Business WireXencor Announces Closing of Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional SharesNASDAQ:XNCRXencor Inc
12/09/202414h47Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XNCRXencor Inc
12/09/202414h45Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:XNCRXencor Inc
11/09/202412h31Business WireXencor Announces Pricing of $175 Million Public Offering of Common StockNASDAQ:XNCRXencor Inc
10/09/202422h34Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:XNCRXencor Inc
 Showing the most relevant articles for your search:NASDAQ:XNCR